APO RESEARCH · REPORT
Organoids
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Product & engineering
Understand the product.
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
Selected research
Market Structure
Global Organoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Read the full market overview
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
From perspective of type, organoids can be split into 3D Organoid Culture, Biochemical Cues and others. In 2018, D3D Organoid Culture took accounted for nearly 71%, which made it the largest segment of global organoids.
North America is the largest consumption region of organoids, with a consumption market share nearly 46% in 2019. The second place is Europe; following North America with the consumption market share over 40% in 2019.
Key manufacturers of global organoids market are Thermo Fisher Scientific, Merck and Corning. The top 3 players totally took up a market share of about 75% in 2019. Thermo Fisher Scientific is in the first place, which accounted for above 34% of global market.
Report Includes
This report provides an overview of the global Organoids market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Organoids and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Organoids revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Organoids market size, projected growth trends, production technologies, key applications, and end-use industries.
Organoids Segment by Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Cellesce
DefiniGEN
OcellO B.V.
HUB Oranoid Technology
3Dnamics Inc.
Organoid Therapeutics
InSphero
Organoids Segment by Type
3D Organoid Culture
Biochemical Cues
Organoids Segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Organoids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Organoids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organoids industry.
Chapter 3: Detailed analysis of Organoids companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organoidsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 3D Organoid Culture
- Biochemical Cues
Applications
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
Companies covered
- Thermo Fisher Scientific
- Merck
- Corning
- STEMCELL Technologies
- Lonza
- Prellis Biologics
- amsbio
- Cellesce
- DefiniGEN
- OcellO B.V.
- HUB Oranoid Technology
- 3Dnamics Inc.
- Organoid Therapeutics
- InSphero
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Organoids Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 3D Organoid Culture
- 1.2.3 Biochemical Cues
- 1.3 Market Analysis by Application
- 1.3.1 Global Organoids Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Biopharmaceutical Companies
- 1.3.3 Contract Research Organizations
- 1.3.4 Academics and Research Institutes
- 1.4 Global Market Growth Prospects
- 1.5 Global Organoids Growth Trends by Region
- 1.5.1 Global Organoids Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Organoids Market Size by Region (2021-2026)
- 1.5.3 Organoids Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Organoids Market Dynamics
- 2.1 Organoids Industry Trends
- 2.2 Organoids Industry Drivers
- 2.3 Organoids Industry Opportunities and Challenges
- 2.4 Organoids Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Organoids Revenue by Company (2021-2026)
- 3.2 Global Organoids Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Organoids Key Company Head office and Area Served
- 3.4 Global Organoids Company, Product Type & Application
- 3.5 Global Organoids Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Organoids Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Organoids Players Market Share by Revenue in 2025
- 3.6.3 2025 Organoids Tier 1, Tier 2, and Tier 3
4 Organoids Market by Type
- 4.1 Global Organoids Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Organoids Market Size by Type (2021-2032)
- 4.3 Global Organoids Market Size Share by Type (2021-2032)
5 Organoids Market by Application
- 5.1 Global Organoids Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Organoids Market Size by Application (2021-2032)
- 5.3 Global Organoids Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermo Fisher Scientific Organoids Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Merck Organoids Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Corning
- 6.3.1 Corning Company Information
- 6.3.2 Corning Business Overview
- 6.3.3 Corning Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Corning Organoids Product Portfolio
- 6.3.5 Corning Recent Developments
- 6.4 STEMCELL Technologies
- 6.4.1 STEMCELL Technologies Company Information
- 6.4.2 STEMCELL Technologies Business Overview
- 6.4.3 STEMCELL Technologies Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 STEMCELL Technologies Organoids Product Portfolio
- 6.4.5 STEMCELL Technologies Recent Developments
- 6.5 Lonza
- 6.5.1 Lonza Company Information
- 6.5.2 Lonza Business Overview
- 6.5.3 Lonza Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Lonza Organoids Product Portfolio
- 6.5.5 Lonza Recent Developments
- 6.6 Prellis Biologics
- 6.6.1 Prellis Biologics Company Information
- 6.6.2 Prellis Biologics Business Overview
- 6.6.3 Prellis Biologics Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Prellis Biologics Organoids Product Portfolio
- 6.6.5 Prellis Biologics Recent Developments
- 6.7 amsbio
- 6.7.1 amsbio Company Information
- 6.7.2 amsbio Business Overview
- 6.7.3 amsbio Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 amsbio Organoids Product Portfolio
- 6.7.5 amsbio Recent Developments
- 6.8 Cellesce
- 6.8.1 Cellesce Company Information
- 6.8.2 Cellesce Business Overview
- 6.8.3 Cellesce Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Cellesce Organoids Product Portfolio
- 6.8.5 Cellesce Recent Developments
- 6.9 DefiniGEN
- 6.9.1 DefiniGEN Company Information
- 6.9.2 DefiniGEN Business Overview
- 6.9.3 DefiniGEN Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 DefiniGEN Organoids Product Portfolio
- 6.9.5 DefiniGEN Recent Developments
- 6.10 OcellO B.V.
- 6.10.1 OcellO B.V. Company Information
- 6.10.2 OcellO B.V. Business Overview
- 6.10.3 OcellO B.V. Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 OcellO B.V. Organoids Product Portfolio
- 6.10.5 OcellO B.V. Recent Developments
- 6.11 HUB Oranoid Technology
- 6.11.1 HUB Oranoid Technology Company Information
- 6.11.2 HUB Oranoid Technology Business Overview
- 6.11.3 HUB Oranoid Technology Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 HUB Oranoid Technology Organoids Product Portfolio
- 6.11.5 HUB Oranoid Technology Recent Developments
- 6.12 3Dnamics Inc.
- 6.12.1 3Dnamics Inc. Company Information
- 6.12.2 3Dnamics Inc. Business Overview
- 6.12.3 3Dnamics Inc. Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 3Dnamics Inc. Organoids Product Portfolio
- 6.12.5 3Dnamics Inc. Recent Developments
- 6.13 Organoid Therapeutics
- 6.13.1 Organoid Therapeutics Company Information
- 6.13.2 Organoid Therapeutics Business Overview
- 6.13.3 Organoid Therapeutics Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Organoid Therapeutics Organoids Product Portfolio
- 6.13.5 Organoid Therapeutics Recent Developments
- 6.14 InSphero
- 6.14.1 InSphero Company Information
- 6.14.2 InSphero Business Overview
- 6.14.3 InSphero Organoids Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 InSphero Organoids Product Portfolio
- 6.14.5 InSphero Recent Developments
7 North America
- 7.1 North America Organoids Market Size (2021-2032)
- 7.2 North America Organoids Market Size by Type
- 7.2.1 North America Organoids Market Size by Type (2021-2026)
- 7.2.2 North America Organoids Market Size by Type (2027-2032)
- 7.2.3 North America Organoids Market Share by Type (2021-2032)
- 7.3 North America Organoids Market Size by Application
- 7.3.1 North America Organoids Market Size by Application (2021-2026)
- 7.3.2 North America Organoids Market Size by Application (2027-2032)
- 7.3.3 North America Organoids Market Share by Application (2021-2032)
- 7.4 North America Organoids Market Size by Country
- 7.4.1 North America Organoids Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Organoids Market Size by Country (2021-2026)
- 7.4.3 North America Organoids Market Size by Country (2027-2032)
- 7.4.4 North America Organoids Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Organoids Market Size (2021-2032)
- 8.2 Europe Organoids Market Size by Type
- 8.2.1 Europe Organoids Market Size by Type (2021-2026)
- 8.2.2 Europe Organoids Market Size by Type (2027-2032)
- 8.2.3 Europe Organoids Market Share by Type (2021-2032)
- 8.3 Europe Organoids Market Size by Application
- 8.3.1 Europe Organoids Market Size by Application (2021-2026)
- 8.3.2 Europe Organoids Market Size by Application (2027-2032)
- 8.3.3 Europe Organoids Market Share by Application (2021-2032)
- 8.4 Europe Organoids Market Size by Country
- 8.4.1 Europe Organoids Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Organoids Market Size by Country (2021-2026)
- 8.4.3 Europe Organoids Market Size by Country (2027-2032)
- 8.4.4 Europe Organoids Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Organoids Market Size (2021-2032)
- 9.2 China Organoids Market Size by Type
- 9.2.1 China Organoids Market Size by Type (2021-2026)
- 9.2.2 China Organoids Market Size by Type (2027-2032)
- 9.2.3 China Organoids Market Share by Type (2021-2032)
- 9.3 China Organoids Market Size by Application
- 9.3.1 China Organoids Market Size by Application (2021-2026)
- 9.3.2 China Organoids Market Size by Application (2027-2032)
- 9.3.3 China Organoids Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Organoids Market Size (2021-2032)
- 10.2 Asia Organoids Market Size by Type
- 10.2.1 Asia Organoids Market Size by Type (2021-2026)
- 10.2.2 Asia Organoids Market Size by Type (2027-2032)
- 10.2.3 Asia Organoids Market Share by Type (2021-2032)
- 10.3 Asia Organoids Market Size by Application
- 10.3.1 Asia Organoids Market Size by Application (2021-2026)
- 10.3.2 Asia Organoids Market Size by Application (2027-2032)
- 10.3.3 Asia Organoids Market Share by Application (2021-2032)
- 10.4 Asia Organoids Market Size by Country
- 10.4.1 Asia Organoids Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Organoids Market Size by Country (2021-2026)
- 10.4.3 Asia Organoids Market Size by Country (2027-2032)
- 10.4.4 Asia Organoids Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Organoids Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Organoids Market Size by Type
- 11.2.1 South America, Middle East & Africa Organoids Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Organoids Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Organoids Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Organoids Market Size by Application
- 11.3.1 South America, Middle East & Africa Organoids Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Organoids Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Organoids Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Organoids Market Size by Country
- 11.4.1 South America, Middle East & Africa Organoids Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Organoids Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Organoids Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Organoids Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst